Skip to main content

Figure 3.

Figure 3

TZT‐1027 causes tumor vasculature shutdown. TZT‐1027 (2 mg/kg) or vehicle (control) was administered intravenously to mice bearing Colon26 tumors. The Evans blue content of tumors was measured at 1, 6 and 24 h after administration. Each point represents the mean ± SD of 10 animals. ***P < 0.001, significantly different from the vehicle treatment group (Student's t‐test).